Periosteum and bone marrow (BM) both contain skeletal stem/progenitor cells (SSCs) that participate in fracture repair. However, the functional difference and selective regulatory mechanisms of SSCs in different locations are unknown due to the lack of specific markers. Here, we report a comprehensive gene expression analysis of bone marrow SSCs (BMSSCs), periosteal SSCs (P-SSCs), and more differentiated osteoprogenitors by using reporter mice expressing Interferon-inducible Mx1 and Nestin GFP , previously known SSC markers. We first defined that the BM-SSCs can be enriched by the combination of Mx1 and Nestin GFP expression, while endogenous P-SSCs can be isolated by positive selection of Mx1, CD105 and CD140a (known SSC markers) combined with the negative selection of CD45, CD31, and osteocalcin GFP (a mature osteoblast marker). Comparative gene expression analysis with FACS-sorted BM-SSCs, P-SSCs, Osterix + preosteoblasts, CD51 + stroma cells and CD45 + hematopoietic cells as controls revealed that BM-SSCs and P-SSCs have high similarity with few potential differences without statistical significance. We also found that CD51 + cells are highly heterogeneous and have little overlap with SSCs. This was further supported by the microarray cluster analysis, where the two SSC populations clustered together but are separate from the CD51 + cells. However, when comparing SSC population to controls, we found several genes that are uniquely upregulated in endogenous SSCs. Amongst these genes, we found KDR (aka Flk1 or VEGFR2) to be most interesting and discovered that it is highly and selectively expressed in P-SSCs. This finding suggests that endogenous P-SSCs are functionally very similar to BM-SSCs with undetectable significant differences in gene expression but there are distinct molecular signatures in P-SSCs, which can be useful to specify P-SSC subset in vivo.
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Introduction
Bone fractures constitute a significant burden to the healthcare system with about 16 million fractures per year in the United States. Majority of fractures heal with adequate treatment, but about 5-10% go on to non-union [1] . Treatment methods include bone grafting, delivery of growth factors, and cell-based therapies. Fundamentally, these attempts to augment the healing process are attempts to stimulate the cells that drive fracture repair [2, 3] . Studies on such therapeutic attempts are based on using or stimulating bone marrow skeletal stem cells (BM-SSCs), also known as bone marrow mesenchymal stem cells (BMSCs) [4] . However, endogenous SSCs are a heterogeneous population and are present in multiple tissue locations including periosteum [5] . It is known that SSCs are necessary for fracture repair, yet whether SSCs in different locations have the same functional properties or if they have distinct functions and regulation necessary for the repair process remain unknown.
At its core, bone fracture healing is a complex process that involves the interplay of multiple cell types derived from different tissue sources. Bone marrow (BM) and periosteum are two of the surrounding tissues intimately involved in fracture repair [6] . However, BM is not necessary for healing to proceed, while removal of periosteal tissues can cause non-union [7] . Indeed, this is a fundamental principle in clinical fracture management. This is further exemplified by cell-labeling studies demonstrating that the major cellular contributors to the fracture callus are periosteal cells [8, 9] . More importantly, it has been reported that P-SSCs may have differing functions than BM-SSCs, whereby P-SSCs display endochondral ossification and intramembranous bone formation, while BM-SSCs only participate in the latter process [10, 11] . These differences suggest that P-SSCs may have different inherent properties compared to BM-SSCs.
Although there is much progress in defining unique gene expression patterns in postnatal skeletal stem cells [12] , to date, little is known about the potential differences between P-SSCs and BM-SSCs. This is partly because no reliable markers exist to isolate each of these cell populations to enable such study. Studies on mouse BM-SSCs have identified multiple markers that isolate a potentially more highly purified population of these cells, including Nestin GFP [13] ,
LepR
Cre (Leptin Receptor) [14] , and Grem1
Cre-ERT (Gremlin 1) [15] . Previously, Myxovirus resistance 1 (Mx1) was also shown to identify long-term resident skeletal stem/progenitor cells in mice via in vivo imaging experiments consistent with their role as BM-SSCs [16] . While fewer markers exist for P-SSCs, Mx1 + cells are also known to reside within the periosteal compartment [16] , and these cells provide downstream osteolineage cells enabling their potential use for studying P-SSCs endogenously.
In this study, we isolated BM-SSCs and P-SSCs from transgenic mice based on expression of Mx1 promoter. BM-SSCs were isolated from BM tissues in transgenic mice expressing Cre activity was induced by intraperitoneal injection of 25 mg/kg of polyinosinic:polycytidylic acid (pIpC, Sigma) every other day for 10 days as described previously [13] . At the indicated time after pIpC induction, mice were subjected to in vivo imaging experiments. All mice were maintained in pathogenfree conditions, and all procedures were approved by Baylor College of Medicine's Institutional Animal Care and Use Committee (IACUC).
Intravital imaging
For in vivo imaging of fluorescent cells in living animals, mice were anesthetized with Combo-III and prepared for a customized two-photon and confocal hybrid microscope (Leica TCS SP8MP with DM6000CFS) specifically designed for live animal imaging, as described in our previous report [16, 21] . Briefly, a small incision was introduced on the scalp of Mx1/Tomato/ Ocn-GFP or Mx1/Tomato/Nestin-GFP mice and the surface of calvaria near the intersection of sagittal and coronal suture was exposed. The mice were then mounted on a 3-D axis motorized stage (Anaheim Automation Anaheim, CA), and the calvarial surface was scanned for second harmonic generation (SHG by femto-second titanium:sapphire laser pulses: 880 nm) from bones to identify the injury sites and the intersection of sagittal and coronal sutures. GFP-expressing cells (488 nm excitation, 505-550 nm detection) and Tomato-expressing cells (561 nm excitation, 590-620 nm detection) were simultaneously imaged by confocal spectral fluorescence detection. All images were recorded with their distances to the intersection of the sagittal and coronal sutures to define their precise location. After in vivo imaging, the scalp was closed using a VICRYL plus suture (Ethicon) as previously described [16] . 3-D Images were reconstructed using the Leica Application Suite software, and osteoblasts were counted.
Post-operative care and Euthanasia
Post-operative care was provided as previously described [16] . Mice were anesthetized with Rodent III (BCM CCM combination with anesthetic DEA-III). Each ml of Rodent III contains ketamine 37.5 mg, xylazine 1.9 mg and acepromazine 0.37 mg (5 ml with 2.45 ml sterile water) and was given at 0.75-1.5 ml/kg by intraperitoneal injection (~0.05 ml/30 g mouse). Mice were kept warm and monitored for recovery from anesthesia via toe pinch responses. For post manipulation, mice were monitored for any signs of infection or discomfort by following BCM-IACUC approved protocols. Animals were sacrificed by isoflurane anesthesia and by CO 2 at the termination of experiments or when discomfort was apparent. This method is consistent with the recommendations of the Panel of Euthanasia of the American Veterinary Medical Association and in BCM-IACUC approved protocols.
Isolation and flow cytometry analysis of mouse SSCs
To isolate periosteal cells, dissected femurs, tibias, pelvis and calvaria from mice were placed in PBS, and the overlying fascia, muscle, and tendon were carefully removed. The bones with periosteum were incubated in ice-cold PBS with 1% FBS for 30 min, and the loosely associated periosteum was peeled off using forceps, scalpel, and dissecting scissors. The soft floating periosteal tissues collected with a 40-μm strainer were then incubated with 5-10 ml of 0.1% collagenase and 10% FBS in PBS at 37˚C for 1 hour, and dissociated periosteal cells were washed with PBS, filtered with a 40-μm strainer and resuspended at~1 x 10 7 cells/ml. 
Microarray analysis
Sorted cells from two or three male and female mice were used to isolate RNA using the RNeasy Micro kit (Qiagen), according to the manufacturer's instructions. Purified RNA was reverse-transcribed, amplified, and labeled with the Affymetrix Gene Chip whole transcript sense target labeling kit. Labeled cDNA (2 biological repeats) from indicated cells was analyzed using Affymetrix mouse A430 microarrays, according to the manufacturer's instructions, performed at the Dana-Farber Cancer Institute Microarray Core. CEL files (containing raw expression measurements) were imported to Partek GS, and data were preprocessed and normalized using the RMA (Robust Multichip Average) algorithm. The NIH GEO accession number for the microarray analysis data included in this paper is GSE107798.
Microarray data analysis and statistics
Microarray data was pre-processed for normalization and statistical differences using R statistical package. Normalization was done using a robust multichip average (RMA) technique. Statistical differences were calculated with the limma package in R. Post-processing cluster analysis was done using Cluster 3.0 software and were plotted using Java TreeView software. Scatter plots were generated using Orange biolab software. We assessed pairwise comparisons between each of the following groups: 1) Mx1
hematopoietic lineage cells; 4) Osterix GFP+ osteoprogenitor cells [23] ; and, 5) CD51 + BMSCs [24] . We evaluated the number of statistically different genes by changing the p-value statistical criteria for acceptance. We found that acceptance criteria of p < 0.05 provided at least 50 statistically different genes between controls and Mx1 + SSCs.
Results

In vivo identification of BM-SSCs and P-SSCs
BM-SSCs and P-SSCs were derived from transgenic mice based on expression of interferoninduced GTP-Binding Protein Mx1 promoter, which has been previously shown to represent long-term resident osteoprogenitor cells [16] . Here, Mx1
Cre ; Rosa Tomato ; Osteocalcin GFP mice were used as previously described [21] . Using this model, we confirmed through pulse-chase labeling studies in native bone marrow tissue (i.e. no injury) that pulse- (Fig 1D) , which is consistent with prior studies as BM-SSCs are generally known to be perivascular cells [13, 26] . For our experiments, we isolated BM-SSCs using this model from the BM tissue compartment, which were sorted by negative selection of CD45, CD31 ) osteoprogenitor cells were used as control populations [23, 27] . From scatter plot analysis of all microarrayed genes, we found that each SSC population is a distinct population as compared to CD45
+ cells (Fig 2A-2C) . We further defined that each SSC population are more closely related to Osx + osteolineage cells, but with multiple differentially expressed genes (Fig 2D-2F Fig 2K) . (Fig 3C) . Genes that were overexpressed are shown in S1 Table. Among the full list of differentially expressed genes, we identified several genes that are highly expressed in both SSC populations (Fig 3D) . Interestingly, we found selectively increased expression of the vascular endothelial growth factor receptors (VEGFR), Flt1 (VEGFR1) and KDR (VEGFR2), in the P-SSC population compared to controls. In addition, we found that the level of KDR expression in P-SSCs is much higher than that of BM-SSCs although it is expressed in both SSC populations (Fig 3D) , implicating that KDR can be a selective marker for P-SSCs. [28] . We first compared our SSC populations to other publically available SSC populations using Gene Expression Commons data (Fig 4A) [29] . We noted that other well-studied BM-SSC markers, Leptin receptor (LepR) and Gremlin 1 (Grem (Fig 4A) . We confirmed these findings by RT-PCR (Fig 4B) , which supported our microarray analysis. We next assessed if KDR is a prospective surface marker for endogenous P-SSCs. We included P-SSCs (CD45 express these markers, implicating that P-SSCs specifically express KDR (n = 3, p < 0.0001, Fig  5D) . To further confirm the KDR and CD140a expression in P-SSCs and to exclude a possible [31, 32] . We found that~76% of Prx1
Determination of differentially expressed genes between P-SSCs and BM-SSCs with controls
P-SSCs are CD140a
− cells have undetectable expression of KDR (Fig 5E, Prx1-GFP-) . Thus, our microarray analysis reliably demonstrated differential gene expression in both BM-SSCs and P-SSCs and we found that P-SSCs have selectively high expression of KDR in vivo.
Discussion
Herein, we sought to assess the functional genetic differences between mouse BM-SSCs and P-SSCs. These cell populations display differing apparent roles in fracture repair, so we hypothesized that their differences would be borne out in genetic expression analyses. We used Mx1
+
Nes
GFP+ cells from BM as BM-SSCs and Mx1
+ Ocn GFP− cells from periosteal tissues as P-SSCs. With these cells, we performed a microarray analysis to compare their functional genetic differences. However, we were unable to find statistically significant difference in gene expression of these two populations. This is not unexpected considering that these both represent skeletal stem/progenitor cell populations, albeit from differing sources. On further analysis, we did find a novel marker for P-SSCs in comparison to BM-SSCs, which was KDR (aka VEGFR2, Fig 5D & 5E) . Additionally, there were other potential candidate genes upregulated in each SSC population in comparison to controls but their functional significance was unclear. Thus, while we did not find differential gene expression by clustered microarray analysis, we were able to find few unique genetic differences suggesting that these two cell populations may have subtle but critical functional differences.
Among the several markers previously demonstrated for SSCs, including Gremlin 1 [30] , Leptin Receptor and Nestin [25] , we chose to isolate SSCs based on expression of Mx1. Unlike other markers, Mx1 + cells were shown to contribute to adult osteolineage cells by live in vivo
imaging. This was further demonstrated here, which confirms their identity as osteolineage cells (Fig 1A) . Given Mx1 marker has been known to label upstream hematopoietic lineage + BM-SSCs (MNS) highly express Leptin receptor (LepR) and Gremlin 1, demonstrating that these SSC populations share characteristics with previously studied early postnatal SSC and progenitor populations [29] . Further, KDR is found to be uniquely expressed in P-SSCs compared to other SSCs. 
BM-SSCs (MNS) and Mx1
+ P-SSCs were sorted, and the levels of the indicated genes were quantified by qPCR.
https://doi.org/10.1371/journal.pone.0190909.g004
Gene expression analysis of bone marrow-and periosteal-skeletal stem/progenitor cells . By comparison, the P-SSC population was further purified by removing Ocn GFP+ adult osteolineage cells from the population. Inherently, our BM-SSC population was a more highly purified population than the P-SSC population used in this study, which is important to recognize for data interpretation. Still, both of these populations were found to express Leptin Receptor and Gremlin 1, showing that these populations are comparable to previously reported SSC populations, and this also supported our microarray findings. We additionally isolated CD51 + cells as another population representing BMSCs for comparison to P-SSCs [17] . This marker along with PDGFR-alpha (CD140a) had previously been shown to be expressed on Nestin GFP+ BM-SSCs [17] . However, in our study, we found that this population was far different from the Mx1 Table) . Cre reporter mice [31, 32] .
Both of these analyses confirmed upregulation of KDR in endogenous P-SSCs (Fig 5E) . With this in mind, the expression of KDR on Mx1 + Ocn − P-SSCs is interesting because P-SSCs are believed to rapidly react to bone injuries and it would represent an efficient control mechanism for both endothelial cells and P-SSCs to respond to the same signaling molecule. Thus, during states of injury or inflammation, both cells would become activated in part for an angiogenic process and in part to initiate bone repair process, which inherently go hand-inhand. Of further note is that periosteal tissue is known to be highly vascularized, and angiogenesis likely proceeds from the periosteal tissue. In either case, we would hope to further explore KDR as a potential regulatory mechanism of P-SSCs.
As part of our analysis, we showed that P-SSCs represent a distinct population from Osx + cells. From prior studies, it was known that both Osx + cells and P-SSCs are involved in endochondral ossification. Considering that Osx deficiencies can cause arrest of endochondral ossification, it would follow that P-SSCs participate in this process by differentiating down an Osx + pathway. Still, differences exist between these two cell populations because P-SSCs represent upstream progenitors. In summary, we performed a microarray analysis on mouse Mx1 + Nes + BM-SSCs and
Mx1
+ Ocn − P-SSCs and found that these are a similar population of cells without apparent differences readily assessed by gene expression analysis. However, our scatter plot analysis did show potential differences in gene expression although it did not reach statistical significance. The inability to find differential gene expression may be related to the residual heterogeneity of the cell populations. Still, both populations were found to express Leptin Receptor and Gremlin 1, which are consistent with their findings as SSCs and also supported the microarray analysis. We also found an interesting uniquely expressed gene in P-SSC, which was KDR. While the significance of this is yet to be determined, it represents an interesting gene because of its relationship to endothelial cells and the angiogenic response and the fact that periosteum is a highly vascularized tissue. Other studies to explore would be single cell analysis or exploring the possibility of environmental cues as the basis for the different functional roles between BM-SSCs and P-SSCs.
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